Cooper Companies

IRS: 942657368
COO

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second- largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.

Founded
1980 (42 years)
Investor RelationsSEC
Revenue
3 billion (2021)

Want to see more? Sign up!